Governor Jared Polis Signs Landmark Obesity and Diabetes Prevention Bill
in 2025 News Releases, OAC Blog, OAC Newsroom on June 12, 2025

FOR IMMEDIATE RELEASE: June 12, 2025 Governor Jared Polis Signs Landmark Obesity and Diabetes Prevention Bill into Law DENVER, CO – Last week, Governor Jared Polis signed Senate Bill 25-048, the Diabetes Prevention & Obesity Treatment Act, into law—marking a significant milestone in Colorado’s commitment to public health and advancing access to evidence-based obesity care
Read Article

The American Diabetes Association and Obesity Action Coalition Celebrate Progress Made Toward Treating and Preventing Obesity in Texas
in 2025 News Releases, OAC Newsroom on May 16, 2025

Austin, TX (May 16, 2025) – The American Diabetes Association® (ADA) and Obesity Action Coalition (OAC) today celebrated the progress made in the Texas House of Representatives this session in advancing understanding about the need to address obesity and its impact on the long-term health of the state. House Bill 2677, sponsored by Rep. Senfronia
Read Article

80+ Organizations Urge Trump Administration to Cut Spending & Reward Innovation by Expanding Access to Obesity Medications
in 2025 News Releases, OAC Blog, OAC Newsroom on April 4, 2025

FOR IMMEDIATE RELEASE: 80+ Organizations Urge Trump Administration to Cut Spending & Reward Innovation by Expanding Access to Obesity Medications A Centers for Medicare & Medicaid Services (CMS) Proposed Rule Would Address Outdated Policy Constraints & Expand Access to Innovative Treatments for Obesity Tampa, FL (April 3, 2025) — Today, the Obesity Action Coalition (OAC)
Read Article

Obesity Action Coalition Thanks the Biden Administration for Proposed Expansion of Obesity Medication Coverage
in 2024 New Releases, OAC Blog, OAC Newsroom on November 26, 2024

FOR IMMEDIATE RELEASE: Tampa, FL — October 18, 2024 — This Thanksgiving week, the Obesity Action Coalition (OAC) extends its gratitude to the Biden Administration for proposing a new rule significantly expanding access to obesity medications for Americans with Medicare and Medicaid coverage. “This is incredible. For more than a decade, the OAC, alongside partner
Read Article

OAC’s Work on GLP-1 Compounding: Advocating for Safety and Access
in OAC Blog on November 19, 2024

The conversation around GLP-1 medications has grown louder in recent years, with these treatments showing great promise for managing obesity. However, challenges like supply shortages and affordability have created barriers for many individuals. In response, patients are turning to compounded GLP-1 medications as an alternative. Leading Conversations on GLP-1 Compounding At the Obesity Action Coalition
Read Article

ObesityWeek 2024 Highlights and a Focus on Patient Voices
in OAC Blog on November 12, 2024

ObesityWeek 2024 in San Antonio brought together more than 3,200 attendees to explore the latest science and policies around obesity. The OAC had the privilege of attending this esteemed conference once again, and we hosted a booth that engaged attendees with information about our mission, advocacy efforts and upcoming initiatives. Our new Stop Weight Bias
Read Article

OAC and OMA Team Up to Share Insights on Obesity Advocacy
in OAC Blog on July 31, 2024

The Obesity Action Coalition (OAC) believes in the importance of advocacy, especially sharing personal stories about living with obesity to change perceptions and eliminate stigma. Part of our work is also improving the way obesity is addressed in healthcare and educating health professionals. That’s why we were honored to team up with the Obesity Medicine
Read Article

Open Enrollment: It’s Time to Review Your Obesity Coverage
in OAC Blog on October 23, 2023

Open enrollment for 2024 healthcare plans starts November 1, 2023, and ends January 15, 2024, in most states. Be sure to check your deadlines as some are shorter or longer. Open enrollment is a period that occurs annually and it’s the time to review your insurance coverage and assess whether it aligns with your current
Read Article